Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Monopolies Bad, MTFs are Good?

I was chatting with the guys at Fidessa Towers the other day about what constitutes the “right” business model for venues in the post MiFID environment.  It’s an interesting question, and one the European regulators seemed to completely ignore when they first introduced MiFID back in November 2007.  The evidence so far is uncertain.  MiFID has undoubtedly broken up the monopolies of the national exchanges and we are all enjoying lower trading fees as a result. At the same time, though, the industry is struggling to manage both the increased technology costs and the greater complexity associated with the post MiFID world.  Buy-sides in particular are claiming that they are paying a high price in terms of lack of transparency and increased transaction complexity.

Any basic economic textbook will tell you that monopolies are not inherently “bad” and that, in some cases, the customer is actually better served by a monopolistic market than a competitive one. Maybe this is one such case?  Some of the MTFs that have emerged seem to face an uncertain future and the broker dark pools that have sprung up have fuelled the debate over trade reporting and transparency.  Both these issues seem to underline the economists’ argument.

The latest moves by the primaries maybe give us a few clues as to their view of the world.  First there was the launch last week of Xetra International Market (XIM) by Deutsche Börse. XIM is a segment on the main Xetra system that will contain 99 non German stocks (i.e. that are listed on other exchanges) that will now be tradable on Xetra.  This looks like the first steps by Deutsche Börse towards becoming much more pan European in its approach and will increase its ability to meet the threat of both MTFS and other primary exchanges.

In a similar vein, the LSE announced its support for hidden orders this week – this will allow it to compete with the dark order books of the MTFs and brokers.  Also, few people can have missed the announcements that NYSE Euronext has invested huge sums in co-location facilities (and that the LSE is doing the same).  It seems that the primaries are now playing to their strengths rather than just launching their own flavour MTFs.  Looking ahead maybe the real battle is going to be between the big guys as they slog it out for European dominance.

The irony, of course, is that the market still needs the MTFs in order to keep pricing pressure on the primaries, yet a multitude of different venues operating under different rules creates operational inefficiency in the market as a whole.  It would seem, therefore, that finding ways to smooth out these inefficiencies must be the goal for anyone interested in keeping the monopolists at bay.

Leave a comment

Copyright © 2018 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.